BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
TZID:Europe/Helsinki
X-WR-TIMEZONE:Europe/Helsinki
BEGIN:VEVENT
UID:486@inflames.utu.fi
DTSTART;TZID=Europe/Helsinki:20260520T120000
DTEND;TZID=Europe/Helsinki:20260520T130000
DTSTAMP:20260512T120203Z
URL:https://inflames.utu.fi/events/inflames-guest-seminar-professor-antoni
 o-lanzavecchia/
SUMMARY:InFLAMES Guest Seminar: Professor Antonio Lanzavecchia
DESCRIPTION:InFLAMES Guest Seminar: Professor Antonio Lanzavecchia\n\nMay 2
 0 at 12:00\n\nin Medisiina C\, Osmo Järvi lecture hall\n\nProfessor Anton
 io Lanzavecchia\, National Institute of Molecular Genetics (INGM)\, Milano
 \, Italy\nImmunodominance in CD8 T cell responses\n\nHost: Sirpa Jalkanen 
 (sirjal@utu.fi)\n\nCoffee and sandwiches served at 11:30.\n\n(Those outsid
 e Turku\, please request the online link from sampo.koivunen@utu.fi by May
  19.)\n\nProfessor Antonio Lanzavecchia is known for his work on antigen p
 resentation\, T cell activation\, immunological memory and human monoclona
 l antibodies. Lanzavecchia obtained a medical degree from the University o
 f Pavia\, where he specialized in paediatrics and in infectious diseases. 
 Since 1983 he works in Switzerland\, first as a scientific member of the B
 asel Institute for Immunology and since 2000 as the founding director of t
 he Institute for Research in Biomedicine in Bellinzona. Lanzavecchia has b
 een professor of Immunology at the University of Genova and Siena and at t
 he Swiss Federal Institute of technology\, ETH Zürich. He is member of th
 e EMBO\, fellow of the Royal College of Physicians and is honorary member 
 of the American Society for Immunology\, of the Swiss Society of Immunolog
 y and of the Swiss Academy of Medical Sciences. In 2016 he has been electe
 d as international member of the U.S. National Academy of Sciences. He rec
 eived the EMBO gold Medal\, the Cloetta prize\, the Robert Koch prize\, th
 e Sanofi-Institut Pasteur prize and the Louis-Jeantet Prize for Medicine. 
 Lanzavecchia is the scientific Founder of Humabs Biomed\, now a subsidiary
  of Vir Biotecnology and is currently senior Research fellow at Vir Biotec
 nology. His academic research continues at the INGM.\n\nSelected publicati
 ons\n\nPhad\, G.E.\, Pinto\, D.\, Foglierini\, M. et al. Clonal structure\
 , stability and dynamics of human memory B cells and circulating plasmabla
 sts. Nat Immunol 23\, 1076–1085 (2022). https://doi.org/10.1038/s41590-0
 22-01230-1 \n\nChen\, Y.\, Xu\, K.\, Piccoli\, L. et al. Structural basis
  of malaria RIFIN binding by LILRB1-containing antibodies. Nature 592\, 63
 9–643 (2021). https://doi.org/10.1038/s41586-021-03378-6\n\nCassotta\, A
 .\, Paparoditis\, P. et al. Deciphering and predicting CD4+ T cell immunod
 ominance of influenza virus hemagglutinin. J Exp Med 5 October 2020\; 217 
 (10): e20200206. doi: https://doi.org/10.1084/jem.20200206\n\n\nJoshua Tan
 \, Luca Piccoli\, Antonio Lanzavecchia. 2019. The Antibody Response to Pla
 smodium falciparum: Cues for Vaccine Design and the Discovery of Receptor-
 Based Antibodies. Annual Review Immunology. 37:225-246. https://doi.org/10
 .1146/annurev-immunol-042617-053301\n\n\n
ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/Anton
 io-Lanzavecchia.jpg
CATEGORIES:Events in English,Tapahtumat
LOCATION:Osmo Järvi lecture hall\, Medisiina B/C\, Kiinamyllynkatu 10\, Tu
 rku\, Finland
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Kiinamyllynkatu 10\, Turku\
 , Finland;X-APPLE-RADIUS=100;X-TITLE=Osmo Järvi lecture hall\, Medisiina 
 B/C:geo:0,0
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:DAYLIGHT
DTSTART:20260329T040000
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR